Filing Flows › Companies › ANI Pharmaceuticals › Earnings quality
ANI Pharmaceuticals earnings quality score
How much of the reported profit is backed by cash, and how many markers of managed earnings the filings show
Score64 / 100 · grade C · rank 596 of 1027
ANI Pharmaceuticals (ANIP) scores 64 of 100 for earnings quality, grade C: rank 596 of 1027 companies and 65 of 126 in health. It loses the most points on adjusted earnings 41% below GAAP, discretionary accruals of -9.6% of assets (modified Jones), larger than most, accruals of -7.9% of assets, lower than 76% of companies (profit backed by cash). It earns full or near-full marks for Dechow F-score 0.51 (normal), profit about as variable as cash flow (smoothness 0.73).
What earned and lost points
| Component | What the filings show | Points | Of |
|---|---|---|---|
| Accruals | accruals of -7.9% of assets, lower than 76% of companies (profit backed by cash) | 20 | 27 |
| Dechow F-score | Dechow F-score 0.51 (normal) | 20 | 20 |
| Montier C-score | Montier C-score 1 of 4 checks failed | 15 | 20 |
| Discretionary accruals | discretionary accruals of -9.6% of assets (modified Jones), larger than most | 2 | 13 |
| Non-GAAP gap | adjusted earnings 41% below GAAP | 0 | 13 |
| Earnings smoothness | profit about as variable as cash flow (smoothness 0.73) | 7 | 7 |
How the score is built
Eight published measures, each scored against the whole universe or on its own scale and weighted: accruals 20, discretionary accruals 10, Beneish M 15, Dechow F 15, Montier C 15, Piotroski F 10, the non-GAAP gap 10, smoothness 5. A measure that cannot be computed (Beneish for a bank, say) drops out and the rest is rescaled, so every company is scored on what applies to it.
Every company ranked → The full quality workbench, live → ANI Pharmaceuticals: cash flow →
Computed from the companies’ own XBRL filings (latest fiscal year) by published formulas; a statistical screen, not an audit or an accusation. A low score means the reported profit shows more of the markers of managed or low-quality earnings than its peers. Not investment advice.